Louis R Derose, MD in Larned, KS - Medicare Provider

Louis R Derose, MD is a medicare enrolled "Psychiatry & Neurology - Psychiatry" provider in Larned, Kansas. His current practice location is 1301 Ks Hwy 264, Larned, Kansas. You can reach out to his office (for appointments etc.) via phone at (620) 285-4507.

Louis R Derose is licensed to practice in Kansas (license number 08-00311) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1538368592.

Contact Information

	Louis R Derose, MD
	1301 Ks Hwy 264, Larned, KS 67550-5353
	(620) 285-4507
	(620) 285-4509

Healthcare Provider's Profile

Full Name	Louis R Derose
Gender	Male
Speciality
Experience	Years
Location	1301 Ks Hwy 264, Larned, Kansas
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Louis R Derose attended and graduated from in

NPI Data:

NPI Number: 1538368592
Provider Enumeration Date: 07/11/2007
Last Update Date: 04/01/2010

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Louis R Derose such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1538368592	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103T00000X	Psychologist	(* (Not Available))	Secondary
2084P0800X	Psychiatry & Neurology - Psychiatry	08-00311 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Louis R Derose is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Louis R Derose, MD 1301 Ks Hwy 264, Larned, KS 67550-5353 Ph: (620) 285-4507	Louis R Derose, MD 1301 Ks Hwy 264, Larned, KS 67550-5353 Ph: (620) 285-4507

News Archive

New metabolic blood profile method could help predict breast cancer

According to the World Health Organization, breast cancer is the most common cancer in women both in the developed and less developed world, and in the long term the scientists hope that the new method will lead to better prevention and early treatment of the disease.

Free health check up ignored by more than half of the population says NHS

The NHS England provided a free health check up to the population over forty years of age and has noted that more than half of them did not take the health check-ups that could detect and treat dementias and other conditions.

Study: Preoperative use of blood-thinning drugs associated with decreased risk of blood clots

Among patients undergoing major cancer operations, the preoperative use of blood-thinning drugs such as heparin does not increase rates of major bleeding or transfusions, and is associated with a decreased risk of blood clots, according to new study results published online in the Journal of the American College of Surgeons ahead of print publication early next year.

CMS to hold Medicare claims for four more days

Doctors treating Medicare patients won't be hit with a steep pay cut Tuesday, as previously scheduled, the Obama administration announced Monday. Instead, the Centers for Medicare and Medicaid Services is holding claims until Friday, anticipating that Congress will intervene this week. The move is the latest in a string of efforts to prevent Medicare doctors from receiving a 21 percent pay cut, which technically went into effect June 1."

HGS receives Complete Response Letter from FDA for ZALBIN drug

Human Genome Sciences, Inc. today announced that, as expected, it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) for 900-mcg ZALBIN (albinterferon alfa-2b, known in Europe as JOULFERON®) dosed every two weeks for the treatment of chronic hepatitis C.

Louis R Derose, MD - Medicare in Larned, KS